|
1
|
The B7-H1 (PD-L1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: correlation with important high-risk prognostic factors.
|
Neoplasia
|
2006
|
3.54
|
|
2
|
Enhancement of lytic activity of leukemic cells by CD8+ cytotoxic T lymphocytes generated against a WT1 peptide analogue.
|
Leuk Lymphoma
|
2009
|
1.47
|
|
3
|
Therapeutic targeting of B7-H1 in breast cancer.
|
Expert Opin Ther Targets
|
2011
|
1.12
|
|
4
|
Doxorubicin downregulates cell surface B7-H1 expression and upregulates its nuclear expression in breast cancer cells: role of B7-H1 as an anti-apoptotic molecule.
|
Breast Cancer Res
|
2010
|
1.03
|
|
5
|
Identification of a novel peptide derived from the M-phase phosphoprotein 11 (MPP11) leukemic antigen recognized by human CD8+ cytotoxic T lymphocytes.
|
Hematol Oncol Stem Cell Ther
|
2010
|
0.76
|